Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 7/20 | 0.42 |
| ▸ | KDR | P35968 | 2/20 | 0.40 |
| ▸ | BRAF | P15056 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 3/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22972139 | 0.78 | SRC (0.48) | KDRBRAFMAPK14TNNI3KSRC | |
| SCHEMBL7651795 | 0.75 | FOLH1 (0.48) | — | |
| SCHEMBL7482565 | 0.72 | SRC (0.53) | TSHRKDRBRAFMAPK14TNNI3K | |
| SCHEMBL9431770 | 0.72 | NCF1 (0.54) | KDRBRAFMAPK14TNNI3K | |
| SCHEMBL22972146 | 0.72 | SRC (0.45) | KDRBRAFMAPK14TNNI3KSRC | |
| SCHEMBL22972260 | 0.71 | SRC (0.46) | TSHRKDRBRAFMAPK14TNNI3K | |
| SCHEMBL28406648 | 0.70 | FOLH1 (0.44) | KMT2A | |
| SCHEMBL24724415 | 0.69 | TSHR (0.47) | TSHRSRCTGFBR1KMT2AMEN1 | |
| SCHEMBL4766092 | 0.69 | RAB9A (0.46) | TSHRBRAFSRCTGFBR1KMT2A | |
| Carbamic Acid SCHEMBL29034270 | 0.68 | ALOX15 (0.54) | KDRSRCTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997037665-A1 | METHOD OF TREATING HEART FAILURE WITH ENDOTHELIN ANTAGONISTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-10-16 | — | — | WO | disclosed |
| EP-0710235-A4 | — | — | 1996-06-12 | — | — | EP | disclosed |
| EP-0710235-A1 | ENDOTHELIN ANTAGONISTS | MERCK & CO. INC. (US) | 1996-05-08 | — | — | EP | disclosed |
| WO-1995008989-A1 | ENDOTHELIN ANTAGONISTS INCORPORATING A CYCLOBUTANE | MERCK & CO., INC. (US) | 1995-04-06 | — | — | WO | disclosed |
| WO-1995003044-A1 | BENZIMIDAZOLINONES SUBSTITUTED WITH PHENOXYPHENYLACETIC ACID DERIVATIVES | MERCK & CO., INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995003295-A1 | ENDOTHELIN ANTAGONISTS | MERCK & CO., INC. (US) | 1995-02-02 | — | — | WO | disclosed |